Quantitative Molecular Evaluation of Minimal Residual Disease in Patients with Chronic Lymphocytic Leukemia: Efficacy of In Vivo Purging by Alemtuzumab (Campath-1H)
暂无分享,去创建一个
S. Galimberti | M. Petrini | S. Pacini | F. Guerrini | R. Fazzi | N. Cecconi | G. Cervetti | F. Caracciolo | C. Manetti